Concepedia

Author

David Bowen

University of PaviaORCID

Also Known As

Bowen, D. T., D Bowen, D T Bowen, D. BOWEN, D. Bowen, D. T. Bowen, D.T. Bowen, David Bowen, David T Bowen, David T. Bowen

343

Publications

36.6K

Citations

74

H-Index

115

Concepts

All Affiliations

University of PaviaRadboud University Medical CenterKarolinska InstitutetRadboud University NijmegenSt James's University Hospital
DB

About

David Bowen is an author at University of Pavia specializing in medicine, hematology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

34

3.1K

2

Health Sciences

12

12

1.9K

3

Engineering

2

2

70

4

Humanities

1

1

20

5

Language Studies

1

1

20

David Bowen

×

121

Publications

24.2K

Citations

59

H-Index

YearCitations

Pan-cancer analysis of whole genomes

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse,

Nature

2020

3.1K

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz,

Blood

2012

3.1K

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati,

Blood

2013

1.8K

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>

Jyoti Nangalia, Charles Massie, E. Joanna Baxter,

New England Journal of Medicine

2013

1.7K

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew,

Blood

2001

1.5K

Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts

Elli Papaemmanuil, Mario Cazzola, Jacqueline Boultwood,

New England Journal of Medicine

2011

1.2K

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Luca Malcovati, Eva Hellström‐Lindberg, David Bowen,

Blood

2013

663

Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

Nicolas Goardon, Emanuele Marchi, Ann Atzberger,

Cancer Cell

2011

634

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills,

The Lancet Oncology

2015

533

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti,

New England Journal of Medicine

2020

519

Page 1